MAR 14, 2016 02:52 PM PDT

Defining the Role of Tumor Necrosis Factor During Chronic Viral Infections

WRITTEN BY: Kara Marker
Some viral infections, like HIV, are chronic, while others are acute. HIV infections are labeled chronic because the virus targets and kills helper T cells, and without these lymphocytes the body cannot fight off the HIV infection. Viruses causing acute infections, like the seasonal “stomach bug,” work differently and can be eliminated by the body.

New research from a collaboration between the University of Bonn, University of Cologne, and the Technical University of Munich has led to the discovery of an explanation for why certain viral infections are chronic and others are not. This same discovery has promise for generating new therapeutic targets.
 
Helper T cells secrete inflammatory messengers, a kind of “distress call” to killer T cells to come to their aid and fight off invading pathogens. However, viruses that cause a chronic infection, like HIV, employ virulence factors to silence these messages, ironically rendering the helper T cells helpless and ineffective.
 
In the recent collaborative study, published in the journal Nature Immunology, scientists studied mice models of chronic viral infection to see which helper T cell genes remain active when silenced by viruses. They were able to implicate tumor necrosis factor (TNF) as an agent of chronic viral infection. TNF controls various signaling pathways that inhibit helper T cell activity during chronic inflammation. In mice suffering from HIV-esque chronic viral infections with TNF inactivated, helper T cells produce inflammatory messengers like normal.
 
TNF plays a role in several different functions.

 
“After ten days, the animals had completely eliminated the virus; they were healthy,” explained Dr. Marc Beyer from the University of Bonn.
 
Meanwhile, during acute viral infections, TNF has the opposite effect. It boosts the immune system and stimulates apoptosis in cells corrupted by viral particles.
 
“In an acute infection, large quantities of TNF are formed very rapidly," said Dr. Zeinab Abdullah from the University of Bonn. "In chronic infections, on the other hand, the body secretes small amounts of TNF over a long period of time. This appears to cause the helper T cells to shut down to some extent."
 
The difference seems to stem from some sort of protective mechanism that prevents healthy tissues from being damaged from persistent inflammation, however the team is still in the dark about how exactly TNF works on a molecular level. For the time being, TNF inhibitors could be useful as a therapeutic treatment for patients with chronic viral infections like they are currently used for patients with rheumatoid arthritis and other autoimmune diseases.
 
 
Source: University of Bonn
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 25, 2018
Immunology
AUG 25, 2018
Maternal Depression Alters Mom and Baby's Immune Markers
Maternal depression alters stress and immune system biomarkers in children leading to social withdrawal and behavioral problems....
OCT 04, 2018
Videos
OCT 04, 2018
Why Do We Have Nightmares With a Fever?
Fever is the body’s response to a threat. When some viruses or bacteria try to enter the body, an immune response begins that can include a sharp ris...
OCT 09, 2018
Drug Discovery
OCT 09, 2018
'Copper Antibiotic Peptide' Effective in Eradicating Tuberculosis
The bacterium responsible for Tuberculosis has found a way to avoid antibiotics by hiding inside the macrophages which are the specific immune cells that a...
NOV 13, 2018
Immunology
NOV 13, 2018
Bacteria Offers Solution to Inflammation
A team of researchers surveys the mutualistic relationship between gut bacteria and host in regards to gut inflammation in zebrafish...
NOV 13, 2018
Immunology
NOV 13, 2018
Yin & Yang: The Duality of Cancer-Associated Fibroblasts in Pancreatic Cancer
Pancreatic Cancer is a devastating disease. Fifty-five thousand new patients were diagnosed this year in the United States (1). It is painful and usua...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Anti-inflammatory Drug Works Like an Inhibitor
At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor. The new anti-...
Loading Comments...